美国全膝关节置换术后无菌性松动翻修病例量与经济负担预测
该研究基于美国全国代表性住院样本,统计2012至2022年因全膝置换术后无菌性松动行翻修术的住院病例与费用,并预测至2032年。
要点
- 2012至2018年美国因无菌性松动行翻修TKA的住院量由15,355例升至18,775例,疫情期间大幅下降。
- 基于疫情前数据预测,2032年该类翻修年住院量将达30,605例,约为2012年的两倍。
- 预计2032年单例住院费用升至40,549美元,年总费用达927,096,500美元,较2012年增长95%。
核心结论
- TKA术后无菌性松动仍是当代重要问题,相关治疗费用巨大,预测美国年住院费用将接近十亿美元。
- 费用上升与疫情积压病例给骨科医生和医疗系统带来重大挑战,需持续加强无菌性松动的预防与管理。
研究设计与样本
- 研究基于美国全国代表性住院样本,识别2012至2022年因无菌性松动行翻修TKA的住院病例。
- 排除18岁以下患者及合并感染者,统计全国估算发病率与经济负担,并按2022年基准年进行通胀调整。
- 利用疫情前数据将无菌性松动相关费用预测至2032年。
主要发现
- 2012年全国住院量为15,355例,2018年升至18,775例,疫情期间病例量大幅下降。
- 单例住院平均费用由2012年的30,920美元升至2022年的34,748美元。
- 预测2032年年住院量达30,605例,接近2012年的两倍。
- 预测2032年单例费用升至40,549美元,较2012年增长31%。
- 预测2032年年总费用达927,096,500美元,较2012年增长95%。
临床怎么用
- 提示骨科医生与医疗系统需关注TKA术后无菌性松动的长期经济负担与病例增长趋势。
- 疫情积压病例可能加剧未来翻修需求,应重视无菌性松动的预防与规范管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aseptic loosening after total knee arthroplasty (TKA) is an important complication often requiring revision surgery. The purpose of this study was to characterize and project the annual incidence and associated total inpatient costs of revision TKA (rTKA) for aseptic loosening. METHODS: Admissions for rTKA performed for aseptic loosening between 2012 and 2022 were identified in a nationally representative sample of hospital admissions in the United States. Patients who were under 18 years of age and those who had concurrent infections were excluded. The estimated national incidence of rTKA for aseptic loosening and the associated economic burden in years 2012 to 2022 were identified. Future costs associated with aseptic loosening were projected to 2032. Costs were adjusted for inflation to a base year of 2022. RESULTS: In 2012, national admission volume was 15,355, rising to 18,775 by 2018. Volumes fell sharply during the pandemic. The average cost of inpatient admission rose from $30,920 in 2012 to $34,748 in 2022. Using pre-pandemic data, the annual national volume of rTKA for aseptic loosening is projected to rise to 30,605 admissions per year by 2032, nearly double the volume in 2012. Costs per case were also projected to rise to $40,549 by 2032, a 31% increase from 2012. Total costs were projected to rise to $927,096,500 per year by 2032, a 95% increase from 2012. CONCLUSIONS: Aseptic loosening following TKA remains a contemporary issue with substantial associated treatment costs. Projections indicate that the annual inpatient cost of treating this condition will approach nearly a billion dollars per year in the United States alone. Rising costs and deferred cases from the pandemic pose major challenges for orthopaedic surgeons and the health-care system. Continued efforts aimed at preventing and managing aseptic loosening in TKA are warranted.
引用
- Pisharody VA, Nour G, Chowdary AR, et al. Projected Case Volume and Economic Burden of Knee Aseptic Loosening in Inpatient Total Knee Arthroplasty in the United States. J Arthroplasty. 2026. PMID: 42498048. doi:10.1016/j.arth.2026.07.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。